Metabolic Infrastructure of Pregnant Women with Fetuses Having Nervous System Abnormalities; Metabolomic Analysis
Abstract
Central nervous system diseases are neurological disorders that affect the structure or function of the brain and spinal cord that make up the central nervous system. In this study, it was aimed to examine the impaired/altered metabolomic profiles of pregnant women carrying fetuses with nervous system abnormalities (NSA). The study group consisted of 30 normal pregnancies with normal fetuses (control group) and 8 pregnancies with fetuses having NSA (study group), as determined by prenatal screening and diagnosis as part of an antenatal care program. Metabolomic analyses were carried out using gas chromatography-mass spectrometry (GC-MS). GC-MS-based metabolomics analysis was able to identify 95 metabolites and 27 of them were statistically significant between the two groups (p<0.05). Moreover, the pathway analysis, performed with significantly altered metabolites, showed alteration in the alanine, aspartate, and glutamate metabolism, citrate cycle, aminoacyl t-RNA biosynthesis, and glutathione metabolism. Alanine, aspartate and glutamate metabolism, citrate cycle, aminoacyl t-RNA biosynthesis, and glutathione metabolism seem to be critical in the prenatal screening of NSAs. However, abnormality-specific studies are necessary for further recommendations.
Keywords
Pregnancy, Congenital nervous system abnormalities, Metabolomics, Prenatal screening, Prenatal diagnosis.
References
- [1] Joan S., Terry L., The basics of brain development, Neuropsychol Rev, 20 (2010 ) 327-348.
- [2] Kaplan K.M,. Spivak J.M., Bendo J.A., Embryology of the spine and associated congenital abnormalities, The Spine Journal, 5 (5) (2005) 564-576.
- [3] Spirt B., Oliphant M., Gordon L., Fetal central nervous system abnormalities, Radiologic Clinics of North America, 28 (1) (1990) 59-73.
- [4] Aydın E., Tanacan A., Büyükeren M., Uçkan H., Yurdakök M., Beksaç M.S., Congenital central nervous system anomalies: Ten-year single center experience on a challenging issue in perinatal medicine, Journal of the Turkish German Gynecological Association, 20 (3) (2019) 170.
- [5] Tanacan A., Ozgen B., Fadiloglu E,. Unal C., Oguz K.K., Beksac M.S., Prenatal diagnosis of central nervous system abnormalities: Neurosonography versus fetal magnetic resonance imaging, European Journal of Obstetrics & Gynecology and Reproductive Biology, 250 (2020) 195-202.
- [6] Pulikkunnel S.T., Thomas S., Neural tube defects: pathogenesis and folate metabolism, The Journal of the Association of Physicians of India, 3 (2005) 127-135.
- [7] Obeid R., Oexle K., Rißmann A., Pietrzik K., Koletzko B., Folate status and health: challenges and opportunities, Journal of perinatal medicine, 44 (3) (2016) 261-268.
- [8] Greene N.D., Leung K.Y., Copp A.J., Inositol, neural tube closure and the prevention of neural tube defects, Birth defects research, 109 (2) (2017) 68-80.
- [9] Beaudin A.E., Stover P.J., Folate‐mediated one‐carbon metabolism and neural tube defects: Balancing genome synthesis and gene expression, Birth Defects Research Part C: Embryo Today: Reviews, 81 (3) (2007) 183-203.
- [10] Stokes B.A., Sabatino J.A., Zohn I.E., High levels of iron supplementation prevents neural tube defects in the Fpn1ffe mouse model, Birth defects research, 109 (2) (2017) 81-91.